Drug information for CLARITIN REDITABS

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, ORALLY DISINTEGRATING; ORAL 10MG Over The Counter  (Reference Drug) LORATADINE Loratadine SCHERING PLOUGH 20704
2009-02-03 Letter

2008-10-23 Letter

2007-03-02 Review

2007-03-02 Review

2006-01-30 Letter

2004-12-07 Review

2003-11-25 Letter

2002-11-27 Letter
TABLET, ORALLY DISINTEGRATING; ORAL 5MG Over The Counter  (Reference Drug) LORATADINE Loratadine SCHERING PLOUGH 21993
2008-10-23 Letter

2008-10-03 Review

2006-12-14 Label

2006-12-14 Letter

Drug Adverse Effects information for CLARITIN REDITABS

Role code Indications Reaction # Reports
C COLORECTAL CANCER CHOLANGITIS 1
C COLORECTAL CANCER DERMATITIS ACNEIFORM 1
C COLORECTAL CANCER DRY SKIN 1
C COLORECTAL CANCER HYPOCALCAEMIA 1
C COLORECTAL CANCER HYPOKALAEMIA 1
C COLORECTAL CANCER HYPOMAGNESAEMIA 1
C COUGH DROWNING 1
C COUGH DRUG ERUPTION 1
C DIABETES MELLITUS BLADDER CANCER 1
C EMPHYSEMA BRONCHITIS 6
C EMPHYSEMA PNEUMONIA 6
C PRODUCT USED FOR UNKNOWN INDICATION DROWNING 7
C PRODUCT USED FOR UNKNOWN INDICATION DRUG ERUPTION 7
C PROPHYLAXIS BRONCHITIS 5
C PROPHYLAXIS PNEUMONIA 5
Ads by Google